Delivery Order SPE2DB22D1017-SPE2DB24FG4LD

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $13,159.40 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,295,968 units of the HIV medication Tivicay 50 mg tablets. The contract has a firm fixed price and an ultimate completion date of July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,882.29 contract is for the supply of 4,567,943,511 units of the pharmaceutical product Tivicay 50 mg Tablet 30s. The contract has an ultimate completion date of April 17, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,671.25, is for the delivery of 4,567,984,596 units of the prescription medication Tivicay 50 mg tablet. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $2,668.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,975,297 units of the medication Tivicay 50 mg Tablet 30s, and has an ultimate completion date of April 22, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and does not utilize any set-aside designations....
The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, through its Corporate Office division, to provide Tivicay 50 mg tablets. The contract has a ceiling value of $1,585.98 and a period of performance through April 2, 2024. This award is a task order placed under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and runs...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $17,083.88 firm-fixed-price contract is for the supply of 4,565,307,744 units of the pharmaceutical product TIVICAY 50 MG TABLET 30S. The contract has an ultimate completion date of August 1, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen...
This federal contract award, with a value of $4,256.57, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tivicay 50 mg tablets and has a completion date of March 5, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award, valued at $4,168.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tivicay 50 mg tablets. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $11,882.91 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of 4,566,275,393 units of TIVICAY 50MG TABS 30S, a pharmaceutical product, with a period of performance through October 31, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between...
This is a $2,565.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TIVICAY 50 MG TABLET 30S, a prescription medication, with a period of performance through July 30, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of pharmaceutical and medical supplies...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG4LD
    Delivery Order

The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract valued at $4,700.16 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,681,900 units of the prescription drug Tivicay 50 mg Tablet 30s. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment facilities and programs worldwide. The contract does not have a set-aside designation and is scheduled for completion by September 5, 2024.

Generated 12/4/24, 9:21 AM